PCM
GMED icon

Parsifal Capital Management’s Globus Medical GMED Stock Holding History

Parsifal Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-387,117
Closed -$33.4M – 18
2026
Q1 		$33.4M Sell
387,117
-835,600
-68% -$75M 3.93% 14
2025
Q4 		$107M Buy
1,222,717
+118,385
+11% +$8.99M 8.76% 4
2025
Q3 		$63.2M Buy
1,104,332
+251,571
+30% +$14.5M 5.89% 8
2025
Q2 		$50.3M Buy
852,761
+106,939
+14% +$6.91M 4.26% 11
2025
Q1 		$54.6M Sell
745,822
-84,581
-10% -$6.99M 4.72% 9
2024
Q4 		$68.7M Sell
830,403
-520,150
-39% -$41M 5.73% 9
2024
Q3 		$96.6M Buy
1,350,553
+453,053
+50% +$32M 6.61% 9
2024
Q2 		$61.5M Buy
+897,500
New +$53.6M 4.44% 9

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Parsifal Capital Management's GMED Position: Q2 2026 in Review

Parsifal Capital Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 387,117 shares — an estimated $33.4M sold.

Parsifal Capital Management first reported a position in GMED in Q2 2024 and held it in 8 quarters. The position peaked at $107M in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Parsifal Capital Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Parsifal Capital Management sold 387,117 Globus Medical shares in Q2 2026, an estimated $33.4M.
  • Parsifal Capital Management first reported a position in Globus Medical in Q2 2024 and held it in 8 quarters.
  • Parsifal Capital Management's Globus Medical position peaked at $107M in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Parsifal Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.